Anesthetic techniques and cancer recurrence after surgery

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Fodale, Vincenzo ^a   D'Arrigo, Maria G ^a   Triolo, Stefania ^a   Mondello, Stefania ^a   La Torre, Domenico ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT;

ANESTHESIA; ARTICLE; CANCER CELL; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CELLULAR IMMUNITY; CLINICAL TRIAL (TOPIC); GENERAL ANESTHESIA; HUMAN; POSTOPERATIVE COMPLICATION; SYSTEMATIC REVIEW; ANIMAL; APOPTOSIS; CELL SURVIVAL; DRUG EFFECTS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; PATHOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD;

ANESTHETICS; ANIMALS; APOPTOSIS; CELL SURVIVAL; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; POSTOPERATIVE PERIOD;

EID: 84896837270     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/328513     Document Type: Article

References (86)

1. Gottschalk A., Sharma S., Ford J., Durieux M. E., Tiouririne M., The role of the perioperative period in recurrence after cancer surgery. Anesthesia and Analgesia 2010 110 6 1636 1643 2-s2.0-77953211466 10.1213/ANE.0b013e3181de0ab6
2. Kvolik S., Glavas-Obrovac L., Bares V., Karner I., Effects of inhalation anesthetics halothane, sevoflurane, and isoflurane on human cell lines. Life Sciences 2005 77 19 2369 2383 2-s2.0-23944499099 10.1016/j.lfs.2004.12.052
3. Mammoto T., Mukai M., Mammoto A., Yamanaka Y., Hayashi Y., Mashimo T., Kishi Y., Nakamura H., Intravenous anesthetic, propofol inhibits invasion of cancer cells. Cancer Letters 2002 184 2 165 170 2-s2.0-0037190808 10.1016/S0304-3835(02)00210-0
4. Itoh T., Namba T., Fukuda K., Semenza G. L., Hirota K., Reversible inhibition of hypoxia-inducible factor 1 activation by exposure of hypoxic cells to the volatile anesthetic halothane. FEBS Letters 2001 509 2 225 229 2-s2.0-0035824784 10.1016/S0014-5793(01)03119-2
5. Melamed R., Bar-Yosef S., Shakhar G., Shakhar K., Ben-Eliyahu S., Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesthesia and Analgesia 2003 97 5 1331 1339 2-s2.0-0142212414
6. Goldfarb Y., Ben-Eliyahu S., Surgery as a risk factor for breast cancer recurrence and metastasis: mediating mechanisms and clinical prophylactic approaches. Breast Disease 2006 26 1 99 114 2-s2.0-34247485994
7. Yamashita J.-I., Kurusu Y., Fujino N., Saisyoji T., Ogawa M., Detection of circulating tumor cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: a potential hazard for intraoperative hematogenous tumor cell dissemination. Journal of Thoracic and Cardiovascular Surgery 2000 119 5 899 905 2-s2.0-0034116326
8. Ben-Eliyahu S., The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain, Behavior, and Immunity 2003 17 1 S27 S36 2-s2.0-0037293044 10.1016/S0889-1591(02)00063-6
9. Demicheli R., Miceli R., Moliterni A., Zambetti M., Hrushesky W. J. M., Retsky M. W., Valagussa P., Bonadonna G., Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process. Annals of Oncology 2005 16 9 1449 1457 2-s2.0-24044520722 10.1093/annonc/mdi280
10. Rosendahl W., Schulz U., Teufel T., Irtel von Brenndorf C., Gupta D., Surgical stress and neuroendocrine responses in infants and children. Journal of Pediatric Endocrinology and Metabolism 1995 8 3 187 194 2-s2.0-0029080108
11. Bar-Yosef S., Melamed R., Page G. G., Shakhar G., Shakhar K., Ben-Eliyahu S., Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology 2001 94 6 1066 1073 2-s2.0-0034982064
12. Dunn G. P., Old L. J., Schreiber R. D., The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004 21 2 137 148 2-s2.0-4143141823 10.1016/j.immuni.2004.07.017
13. Melamed R., Rosenne E., Shakhar K., Schwartz Y., Abudarham N., Ben-Eliyahu S., Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a β -adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain, Behavior, and Immunity 2005 19 2 114 126 2-s2.0-12344326829 10.1016/j.bbi.2004.07.004
14. Page G. G., Surgery-induced immunosuppression and postoperative pain management. AACN Clinical Issues 2005 16 3 302 418 2-s2.0-27744555908
15. Tartter P. I., Steinberg B., Barron D. M., Martinelli G., The prognostic significance of natural killer cytotoxicity in patients with colorectal cancer. Archives of Surgery 1987 122 11 1264 1268 2-s2.0-0023622518
16. Koda K., Saito N., Takiguchi N., Oda K., Nunomura M., Nakajima N., Preoperative natural killer cell activity: correlation with distant metastases in curatively research colorectal carcinomas. International Surgery 1997 82 2 190 193 2-s2.0-0030878746
17. Takeuchi H., Maehara Y., Tokunaga E., Koga T., Kakeji Y., Sugimachi K., Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis. American Journal of Gastroenterology 2001 96 2 574 578 2-s2.0-0035123548 10.1016/S0002-9270(00)02328-5
18. Fujisawa T., Yamaguchi Y., Autologous tumor killing activity as a prognostic factor in primary resected nonsmall cell carcinoma of the lung. Cancer 1997 79 3 474 481
19. Brittenden J., Heys S. D., Ross J., Eremin O., Natural killer cells and cancer. Cancer 1996 77 1226 11243
20. Schantz S. P., Savage H. E., Racz T., Liu F. J., Brown B. W., Rossen R. D., Hong W. K., Immunologic deteminants of head and neck cancer response to induction chemotherapy. Journal of Clinical Oncology 1989 7 7 857 864 2-s2.0-0024475298
21. Kurosawa S., Kato M., Anesthetics, immune cells, and immune responses. Journal of Anesthesia 2008 22 3 263 277 2-s2.0-49649107782 10.1007/s00540-008- 0626-2
22. Reiche E. M. V., Nunes S. O. V., Morimoto H. K., Stress, depression, the immune system, and cancer. The Lancet Oncology 2004 5 10 617 625 2-s2.0-4644292447 10.1016/S1470-2045(04)01597-9
23. Thaker P. H., Sood A. K., Neuroendocrine influences on cancer biology. Seminars in Cancer Biology 2008 18 3 164 170 2-s2.0-43049094088 10.1016/j.semcancer.2007.12.005
24. Sood A. K., Bhatty R., Kamat A. A., Landen C. N., Han L., Thaker P. H., Li Y., Gershenson D. M., Lutgendorf S., Cole S. W., Stress hormone-mediated invasion of ovarian cancer cells. Clinical Cancer Research 2006 12 2 369 375 2-s2.0-31544465011 10.1158/1078-0432.CCR-05-1698
25. Landen C. N. Jr., Lin Y. G., Pena G. N. A., Das P. D., Arevalo J. M., Kamat A. A., Han L. Y., Jennings N. B., Spannuth W. A., Thaker P. H., Lutgendorf S. K., Savary C. A., Sanguino A. M., Lopez-Berestein G., Cole S. W., Sood A. K., Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. Cancer Research 2007 67 21 10389 10396 2-s2.0-35948981785 10.1158/0008-5472.CAN-07-0858
26. Lutgendorf S. K., Cole S., Costanzo E., Bradley S., Coffin J., Jabbari S., Rainwater K., Ritchie J. M., Yang M., Sood A. K., Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clinical Cancer Research 2003 9 12 4514 4521 2-s2.0-10744220803
27. Benish M., Bartal I., Goldfarb Y., Levi B., Avraham R., Raz A., Ben-Eliyahu S., Perioperative use of β -blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Annals of Surgical Oncology 2008 15 7 2042 2052 2-s2.0-46149121727 10.1245/s10434-008- 9890-5
28. Yang E. V., Sood A. K., Chen M., Li Y., Eubank T. D., Marsh C. B., Jewell S., Flavahan N. A., Morrison C., Yeh P.-E., Lemeshow S., Glaser R., Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Research 2006 66 21 10357 10364 2-s2.0-33751261895 10.1158/0008-5472.CAN-06-2496
29. Masur K., Niggemann B., Zanker K. S., Entschladen F., Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by β -blockers. Cancer Research 2001 61 7 2866 2869 2-s2.0-0035300538
30. Kundu J. K., Surh Y.-J., Inflammation: gearing the journey to cancer. Mutation Research 2008 659 1-2 15 30 2-s2.0-47849098044 10.1016/j.mrrev.2008.03. 002
31. Sacerdote P., Manfredi B., Bianchi M., Panerai A. E., Intermittent but not continuous inescapable footshock stress affects immune responses and immunocyte beta-endorphin concentrations in the rat. Brain, Behavior, and Immunity 1994 8 3 251 260 2-s2.0-0027942460 10.1006/brbi.1994.1023
32. Shavit Y., Martin F. C., Yirmiya R., Ben-Eliyahu S., Terman G. W., Weiner H., Gale R. P., Liebeskind J. C., Effects of a single administration of morphine or footshock stress on natural killer cell cytotoxicity. Brain Behavior and Immunity 1987 1 4 318 328 2-s2.0-0023498170
33. Lewis J. W., Shavit Y., Terman G. W., Apparent involvement of opioid peptides in stress-induced enhancement of tumor growth. Peptides 1983 4 5 635 638 2-s2.0-0021084707 10.1016/0196-9781(83)90010-4
34. Page G. G., Blakely W. P., Ben-Eliyahu S., Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain 2001 90 1-2 191 199 2-s2.0-0035252101 10.1016/S0304-3959(00)00403-6
35. Sessler D. I., Does regional analgesia reduce the risk of cancer recurrence? A hypothesis. European Journal of Cancer Prevention 2008 17 3 269 272 2-s2.0-42249101048 10.1097/CEJ.0b013e3282f0c005
36. Arain M. R., Buggy D. J., Anesthesia for cancer patients. Current Opinion in Anaesthesiology 2007 20 247 253 10.1097/ACO.0b013e32814f1c34
37. Santamaria L. B., Schifilliti D., La Torre D., Fodale V., Drugs of anaesthesia and cancer. Surgical Oncology 2010 19 2 63 81 2-s2.0-77952580978 10.1016/j.suronc.2009.03.007
38. Kawaraguchi Y., Horikawa Y. T., Murphy A. N., Murray F., Miyanohara A., Ali S. S., Head B. P., Patel P. M., Roth D. M., Patel H. H., Volatile anesthetics protect cancer cells against tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via caveolins. Anesthesiology 2011 115 3 499 508 2-s2.0-80052145817 10.1097/ALN.0b013e3182276d42
39. Jun R., Gui-He Z., Xing-Xing S., Hui Z., Li-Xian X., Isoflurane enhances malignancy of head and neck squamous cell carcinoma cell lines: a preliminary study in vitro. Oral Oncology 2011 47 5 329 333 2-s2.0-79956220513 10.1016/j.oraloncology.2011.03.002
40. Schifilliti D., Mondello S., D'Arrigo M. G., Chill G., Fodale V., Genotoxic effects of anesthetic agents: an update. Expert Opinion on Drug Safety 2011 10 6 891 899 2-s2.0-80054739858 10.1517/14740338.2011.586627
41. Inada T., Kubo K., Kambara T., Shingu K., Propofol inhibits cyclo-oxygenase activity in human monocytic THP-1 cells. Canadian Journal of Anesthesia 2009 56 3 222 229 2-s2.0-61449086255 10.1007/s12630-008-9035-0
42. Shakhar G., Ben-Eliyahu S., In vivo β -adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. Journal of Immunology 1998 160 7 3251 3258 2-s2.0-0032055982
43. Galley H. F., Dubbels A. M., Webster N. R., The effect of midazolam and propofol on interleukin-8 from human polymorphonuclear leukocytes. Anesthesia and Analgesia 1998 86 6 1289 1293 2-s2.0-0031840310 10.1097/00000539-199806000- 00030
44. Zheng W., Li Y.-P., Lai R.-C., Lu Y.-L., Shen Z.-W., Wang X.-D., Effects of neuraxial block and general anesthesia on tumor metastasis in rats. Nan Fang Yi Ke Da Xue Xue Bao 2008 28 12 2218 2220 2-s2.0-77449136167
45. Exadaktylos A. K., Buggy D. J., Moriarty D. C., Mascha E., Sessler D. I., Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 2006 105 4 660 664 2-s2.0-33749165919 10.1097/00000542-200610000-00008
46. Deegan C. A., Buggy D. J., Moriarty D. C., Sessler D. I., Kavanagh D. P., Anesthetic technique and the cytokine response to primary breast cancer surgery. A841 Proceedings of the ASA Annual Meeting 2008 Orlando, Fla, USA
47. Yoon J. R., Whipple R. A., Balzer E. M., Cho E. H., Matrone M. A., Peckham M., Martin S. S., Local anesthetics inhibit kinesin motility and microtentacle protrusions in human epithelial and breast tumor cells. Breast Cancer Research and Treatment 2011 129 3 691 701 2-s2.0-80052580680 10.1007/s10549-010-1239-7
48. Ke J. J., Zhan J., Feng X. B., Wu Y., Rao Y., Wang Y.-L., A comparison of the effect of total intravenous anaesthesia with propofol and remifentanil and inhalational anaesthesia with isoflurane on the release of pro- and anti-inflammatory cytokines in patients undergoing open cholecystectomy. Anaesthesia and Intensive Care 2008 36 1 74 78 2-s2.0-38949186743
49. Ren X. F., Li W. Z., Meng F. Y., Lin C. F., Differential effects of propofol and isoflurane on the activation of T-helper cells in lung cancer patients. Anaesthesia 2010 65 5 478 482 2-s2.0-77950887827 10.1111/j.1365-2044. 2010.06304.x
50. Biki B., Mascha E., Moriarty D. C., Fitzpatrick J. M., Sessler D. I., Buggy D. J., Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology 2008 109 2 180 187 2-s2.0-48849099857 10.1097/ALN.0b013e31817f5b73
51. Tsui B. C. H., Rashiq S., Schopflocher D., Murtha A., Broemling S., Pillay J., Finucane B. T., Epidural anesthesia and cancer recurrence rates after radical prostatectomy. Canadian Journal of Anesthesia 2010 57 2 107 112 2-s2.0-77950342468 10.1007/s12630-009-9214-7
52. Xing C.-Y., Wu M.-Y., Fan H.-P., Effects of different anesthetic and analgesic protocols on cellular immune function and stress hormone level in patients undergoing lobectomy for esophagus cancer. Nan Fang Yi Ke Da Xue Xue Bao 2010 30 2 284 287 2-s2.0-80051563527
53. Ismail H., Ho K. M., Narayan K., Kondalsamy-Chennakesavan S., Effect of neuraxial anaesthesia on tumour progression in cervical cancer patients treated with brachytherapy: a retrospective cohort study. British Journal of Anaesthesia 2010 105 2 145 149 2-s2.0-77954841386 10.1093/bja/aeq156
54. Lin L., Liu C., Tan H., Ouyang H., Zhang Y., Zeng W., Anaesthetic technique may affect prognosis for ovarian serous adenocarcinoma: a retrospective analysis. British Journal of Anaesthesia 2011 106 6 814 822 2-s2.0-79957484161 10.1093/bja/aer055
55. Gupta A., Björnsson A., Fredriksson M., Hallböök O., Eintrei C., Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery: a retrospective analysis of data from 655 patients in Central Sweden. British Journal of Anaesthesia 2011 107 2 164 170 2-s2.0-79960483522 10.1093/bja/aer100
56. De Oliveira G. S. Jr., Ahmad S., Schink J. C., Singh D. K., Fitzgerald P. C., McCarthy R. J., Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery. Regional Anesthesia and Pain Medicine 2011 36 3 271 277 2-s2.0-79955578501 10.1097/AAP. 0b013e318217aada
57. Christopherson R., James K. E., Tableman M., Marshall P., Johnson F. E., Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia. Anesthesia and Analgesia 2008 107 1 325 332 2-s2.0-49849091929 10.1213/ane.0b013e3181770f55
58. Schlagenhauff B., Ellwanger U., Breuninger H., Stroebel W., Rassner G., Garbe C., Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma. Melanoma Research 2000 10 2 165 169 2-s2.0-0034104435
59. Ben-Eliyahu S., Page G. G., Yirmiya R., Shakhar G., Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. International Journal of Cancer 1999 80 6 880 888 2-s2.0-0033559181
60. Gupta K., Kshirsagar S., Chang L., Schwartz R., Law P.-Y., Yee D., Hebbel R. P., Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Research 2002 62 15 4491 4498 2-s2.0-0036682055
61. Singhal P. C., Kapasi A. A., Reddy K., Franki N., Gibbons N., Ding G., Morphine promotes apoptosis in jurkat cells. Journal of Leukocyte Biology 1999 66 4 650 658 2-s2.0-0032885219
62. Page G. G., Ben-Eliyahu S., Yirmiya R., Liebeskind J. C., Morphine attenuates surgery-induced enhancement of metastatic colonization in rats. Pain 1993 54 1 21 28 2-s2.0-0027264039 10.1016/0304-3959(93)90095-7
63. Shavit Y., Ben-Eliyahu S., Zeidel A., Beilin B., Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats: dose and timing study. NeuroImmunoModulation 2004 11 4 255 260 2-s2.0-3142692604 10.1159/000078444
64. Yeager M. P., Procopio M. A., Deleo J. A., Arruda J. L., Hildebrandt L., Howell A. L., Intravenous fentanyl increases natural killer cell cytotoxicity and circulating CD16+ lymphocytes in humans. Anesthesia and Analgesia 2002 94 1 94 99 2-s2.0-0036138715
65. Mathew B., Lennon F. E., Siegler J., Mirzapoiazova T., Mambetsariev N., Sammani S., Gerhold L. M., Lariviere P. J., Chen C.-T., Garcia J. G. N., Salgia R., Moss J., Singleton P. A., The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation. Anesthesia and Analgesia 2011 112 3 558 567 2-s2.0-79952455322 10.1213/ANE.0b013e31820568af
66. Min T. J., Park S.-H., Ji Y.-H., Lee Y.-S., Kim T. W., Kim J. H., Kim W.-Y., Park Y.-C., Morphine attenuates endothelial cell adhesion molecules induced by the supernatant of LPS-stimulated colon cancer cells. Journal of Korean Medical Science 2011 26 6 747 752 2-s2.0-79958289184 10.3346/jkms.2011. 26.6.747
67. Page G. G., Mcdonald J. S., Ben-Eliyahu S., Pre-operative versus postoperative administration of morphine: impact on the neuroendocrine, behavioural, and metastatic-enhancing effects of surgery. British Journal of Anaesthesia 1998 81 2 216 223 2-s2.0-0031873014
68. Fuggetta M. P., Di Francesco P., Falchetti R., Cottarelli A., Rossi L., Tricarico M., Lanzilli G., Effect of morphine on cell-mediated immune responses of human lymphocytes against allogeneic malignant cells. Journal of Experimental and Clinical Cancer Research 2005 24 2 255 263 2-s2.0-22844436846
69. Yeager M. P., Colacchio T. A., Yu C. T., Hildebrandt L., Howell A. L., Weiss J., Guyre P. M., Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology 1995 83 3 500 508 2-s2.0-0029029825 10.1097/00000542-199509000-00008
70. Beilin B., Shavit Y., Hart J., Mordashov B., Cohn S., Notti I., Bessler H., Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesthesia and Analgesia 1996 82 3 492 497 2-s2.0-0029912570 10.1097/00000539-199603000-00011
71. Sessler D. I., Ben-Eliyahu S., Mascha E. J., Parat M.-O., Buggy D. J., Can regional analgesia reduce the risk of recurrence after breast cancer?. Methodology of a multicenter randomized trial. Contemporary Clinical Trials 2008 29 4 517 526 2-s2.0-44149100983 10.1016/j.cct.2008.01.002
72. Deegan C. A., Murray D., Doran P., Ecimovic P., Moriarty D. C., Buggy D. J., Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro. British Journal of Anaesthesia 2009 103 5 685 690 2-s2.0-74949119662 10.1093/bja/aep261
73. Forget P., Collet V., Lavand'homme P., De Kock M., Does analgesia and condition influence immunity after surgery? Effects of fentanyl, ketamine and clonidine on natural killer activity at different ages. European Journal of Anaesthesiology 2010 27 3 233 240 2-s2.0-77953797224 10.1097/EJA. 0b013e32832d540e
74. Curatolo M., Adding regional analgesia to general anaesthesia: increase of risk or improved outcome? European Journal of Anaesthesiology 2010 27 7 586 591 2-s2.0-77953743328 10.1097/EJA.0b013e32833963c8
75. Snyder G. L., Greenberg S., Effect of anaesthetic technique and other perioperative factors on cancer recurrence. British Journal of Anaesthesia 2010 105 2 106 115 2-s2.0-77954843916 10.1093/bja/aeq164
76. Wuethrich P. Y., Schmitz S.-F. H., Kessler T. M., Thalmann G. N., Studer U. E., Stueber F., Burkhard F. C., Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: a retrospective study. Anesthesiology 2010 113 3 570 576 2-s2.0-77956985315 10.1097/ALN.0b013e3181e4f6ec
77. Looney M., Doran P., Buggy D. J., Effect of anesthetic technique on serum vascular endothelial growth factor C and transforming growth factor β in women undergoing anesthesia and surgery for breast cancer. Anesthesiology 2010 113 5 1118 1125 2-s2.0-78049331340 10.1097/ALN.0b013e3181f79a69
78. Deegan C. A., Murray D., Doran P., Moriarty D. C., Sessler D. I., Mascha E., Kavanagh B. P., Buggy D. J., Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery. Regional Anesthesia and Pain Medicine 2010 35 6 490 495 2-s2.0-78149252955 10.1097/AAP.0b013e3181ef4d05
79. Gottschalk A., Ford J. G., Regelin C. C., You J., Mascha E. J., Sessler D. I., Durieux M. E., Nemergut E. C., Association between epidural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiology 2010 113 1 27 34 2-s2.0-77954174203 10.1097/ALN.0b013e3181de6d0d
80. Myles P. S., Peyton P., Silbert B., Hunt J., Rigg J. R. A., Sessler D. I., ANZCA Trials Group Investigators A. T. G. I., Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial. British Medical Journal 2011 342, article d1491 2-s2.0-79957478322 10.1136/bmj.d1491
81. Forget P., Tombal B., Scholtès J.-L., Nzimbala J., Meulders C., Legrand C., Van Cangh P., Cosyns J.-P., De Kock M., Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer? European Journal of Anaesthesiology 2011 28 12 830 835 2-s2.0-84856503197 10.1097/EJA.0b013e32834b7d9a
82. Tavare A. N., Perry N. J. S., Benzonana L. L., Takata M., Ma D., Cancer recurrence after surgery: direct and indirect effects of anesthetic agents. International Journal of Cancer 2012 130 6 1237 1250 2-s2.0-84856114839 10.1002/ijc.26448
83. Lindholm M.-L., Granath F., Eriksson L. I., Sandin R., Malignant disease within 5 years after surgery in relation to duration of sevoflurane anesthesia and time with bispectral index under 45. Anesthesia and Analgesia 2011 113 4 778 783 2-s2.0-80053337738 10.1213/ANE.0b013e31821f950e
84. Palm D., Lang K., Niggemann B., Drell T. L. IV, Masur K., Zaenker K. S., Entschladen F., The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by β -blockers. International Journal of Cancer 2006 118 11 2744 2749 2-s2.0-33646371479 10.1002/ijc.21723
85. Afsharimani B., Cabot P., Parat M.-O., Morphine and tumor growth and metastasis. Cancer and Metastasis Reviews 2011 30 2 225 238 2-s2.0-79960991208 10.1007/s10555-011-9285-0
86. Bovill J. G., Surgery for cancer: does anesthesia matter? Anesthesia and Analgesia 2010 110 6 1524 1526 2-s2.0-77953228627 10.1213/ANE.0b013e3181d8d183